Cargando…

Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review

BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier pha...

Descripción completa

Detalles Bibliográficos
Autores principales: Matteo, Serenelli, Anna, Cantone, Federico, Sanguettoli, Daniele, Maio, Gioele, Fabbri, Beatrice, Dal Passo, Rita, Pavasini, Elisabetta, Tonet, Giulia, Passarini, Claudio, Rapezzi, Gianluca, Campo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911429/
https://www.ncbi.nlm.nih.gov/pubmed/36776259
http://dx.doi.org/10.3389/fcvm.2023.1085824
_version_ 1784884987056619520
author Matteo, Serenelli
Anna, Cantone
Federico, Sanguettoli
Daniele, Maio
Gioele, Fabbri
Beatrice, Dal Passo
Rita, Pavasini
Elisabetta, Tonet
Giulia, Passarini
Claudio, Rapezzi
Gianluca, Campo
author_facet Matteo, Serenelli
Anna, Cantone
Federico, Sanguettoli
Daniele, Maio
Gioele, Fabbri
Beatrice, Dal Passo
Rita, Pavasini
Elisabetta, Tonet
Giulia, Passarini
Claudio, Rapezzi
Gianluca, Campo
author_sort Matteo, Serenelli
collection PubMed
description BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier phases and does not represent well the pathophysiology of CA. Many echocardiographic parameters resulted important diagnostic and prognostic tools in patients with CA. Stroke volume (SV) and myocardial contraction fraction (MCF) may be obtained both with echocardiography and cardiac magnetic resonance (MRI). They reflect many factors intrinsically related to the pathophysiology of CA and are therefore potentially associated with symptoms and prognosis in CA. OBJECTIVES: To collect and summarize the current evidence on SV and MCF and their clinical and prognostic role in transthyretin (TTR-CA). METHODS AND RESULTS: We performed a systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature database for studies focusing on SV and MCF in patients with TTR-CA. We analysed the following databases: PUBMED, Cochrane Library, EMBASE, and Web of Science database. Fourteen studies were included in the review. Both SV and MCF have important prognostic implications and are related to mortality. Furthermore, SV is more related to symptoms than LVEF and predicts tolerability of beta-blocker therapy in TTR-CA. Finally, SV showed to be an excellent measure to suggest the presence of TTR-CA in patients with severe aortic stenosis. CONCLUSION: Stroke volume and MCF are very informative parameters that should be routinely assessed during the standard echocardiographic examination of all patients with TTR-CA. They carry a prognostic role while being associated with patients’ symptoms. SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.17605/OSF.IO/ME7DS.
format Online
Article
Text
id pubmed-9911429
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-99114292023-02-11 Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review Matteo, Serenelli Anna, Cantone Federico, Sanguettoli Daniele, Maio Gioele, Fabbri Beatrice, Dal Passo Rita, Pavasini Elisabetta, Tonet Giulia, Passarini Claudio, Rapezzi Gianluca, Campo Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Cardiac amyloidosis (CA) is primarily a restrictive cardiomyopathy in which the impairment of diastolic function is dominant. Despite this, the left ventricular ejection fraction (LVEF) may be depressed in the late stage of the disease, but it poorly predicts prognosis in the earlier phases and does not represent well the pathophysiology of CA. Many echocardiographic parameters resulted important diagnostic and prognostic tools in patients with CA. Stroke volume (SV) and myocardial contraction fraction (MCF) may be obtained both with echocardiography and cardiac magnetic resonance (MRI). They reflect many factors intrinsically related to the pathophysiology of CA and are therefore potentially associated with symptoms and prognosis in CA. OBJECTIVES: To collect and summarize the current evidence on SV and MCF and their clinical and prognostic role in transthyretin (TTR-CA). METHODS AND RESULTS: We performed a systematic review following the Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines. We searched the literature database for studies focusing on SV and MCF in patients with TTR-CA. We analysed the following databases: PUBMED, Cochrane Library, EMBASE, and Web of Science database. Fourteen studies were included in the review. Both SV and MCF have important prognostic implications and are related to mortality. Furthermore, SV is more related to symptoms than LVEF and predicts tolerability of beta-blocker therapy in TTR-CA. Finally, SV showed to be an excellent measure to suggest the presence of TTR-CA in patients with severe aortic stenosis. CONCLUSION: Stroke volume and MCF are very informative parameters that should be routinely assessed during the standard echocardiographic examination of all patients with TTR-CA. They carry a prognostic role while being associated with patients’ symptoms. SYSTEMATIC REVIEW REGISTRATION: https://doi.org/10.17605/OSF.IO/ME7DS. Frontiers Media S.A. 2023-01-27 /pmc/articles/PMC9911429/ /pubmed/36776259 http://dx.doi.org/10.3389/fcvm.2023.1085824 Text en Copyright © 2023 Matteo, Anna, Federico, Daniele, Gioele, Beatrice, Rita, Elisabetta, Giulia, Claudio and Gianluca. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Matteo, Serenelli
Anna, Cantone
Federico, Sanguettoli
Daniele, Maio
Gioele, Fabbri
Beatrice, Dal Passo
Rita, Pavasini
Elisabetta, Tonet
Giulia, Passarini
Claudio, Rapezzi
Gianluca, Campo
Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title_full Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title_fullStr Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title_full_unstemmed Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title_short Stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: A systematic review
title_sort stroke volume and myocardial contraction fraction in transthyretin amyloidosis cardiomyopathy: a systematic review
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911429/
https://www.ncbi.nlm.nih.gov/pubmed/36776259
http://dx.doi.org/10.3389/fcvm.2023.1085824
work_keys_str_mv AT matteoserenelli strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT annacantone strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT federicosanguettoli strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT danielemaio strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT gioelefabbri strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT beatricedalpasso strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT ritapavasini strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT elisabettatonet strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT giuliapassarini strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT claudiorapezzi strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview
AT gianlucacampo strokevolumeandmyocardialcontractionfractionintransthyretinamyloidosiscardiomyopathyasystematicreview